Nav: Home

Cornell, Sloan Kettering partner in $10M cancer center

September 29, 2015

ITHACA, N.Y. - Cornell University, in partnership with Memorial Sloan Kettering Cancer Center (MSKCC), is opening a new $10 million Center of Cancer Nanotechnology Excellence that brings together scientists, engineers, biologists and physicians to develop and translate new cancer care applications based on nanotechnology.

The MSKCC-Cornell Center for Translation of Cancer Nanomedicines is funded with an $8.2 million grant from the National Cancer Institute's Alliance for Nanotechnology in Cancer and more than $1.9 million from MSKCC. The center - which will have one facility in Duffield Hall on the Ithaca campus and another at MSKCC in New York City - will focus on melanoma (skin) and malignant brain cancers.

The MSKCC-Cornell Center is based on development and translation of Cornell dots, or C dots - silica-organic hybrid nanoparticles smaller than 10 nanometers in size designed to either adhere to and light up cancer cells or quickly leave the body. C dots are being tested in human clinical trials, opening the door to transformative research and development of new clinically promising classes of nanoparticles and their applications in cancer diagnostics, surgery and targeted drug delivery.

Work in the MSKCC-Cornell Center will include development of intraoperative optical detection tools to improve cancer localization, staging and treatment, as well as optimized therapeutic platforms that enhance delivery relative to existing technologies.

"We couldn't be more proud to have this center supporting the partnership between Cornell and MSKCC," said Lance Collins, the Joseph Silbert Dean of Engineering. "This moment is the culmination of many years of innovative work by many exceptional researchers at both institutions. Without the foundational success of C dots, we likely would not have been successful with the grant."

Uli Wiesner, C dot creator and the Spencer T. Olin Professor of Materials Science and Engineering, stresses collaboration as key to the success of the center, which he will co-direct with Dr. Michelle Bradbury, director of intraoperative imaging at MSKCC and associate professor of radiology at Weill Cornell Medical College.

"You can't do this alone," Wiesner said. "The medical community doesn't have enough know-how of nanomaterials, and we, the scientists and engineers, don't have enough experience in the medical area. But to keep a team together for over 10 years to successfully translate an idea from conception to human clinical trials is not easy."

Bradbury said: "It is truly remarkable to see how this highly versatile particle platform has evolved to address such a broad range of diagnostic and therapeutic cancer applications - that through the aegis of our Cancer Nanotechnology Center - should ultimately impact patient outcomes and quality of life. My long-standing collaboration with Uli has been essential to making this a reality."

Wiesner added that the center exemplifies how seed money can blossom. Wiesner and Bradbury were first brought together to work on nanoparticles through a small grant from Weill Cornell's Clinical and Translational Science Center. Over a decade later, a concept has evolved into a science that warrants its own research center.

"This is a stamp of approval by the research and medical communities that the early risk we took by focusing solely on sub-10 nanometer particles for clinical translation in the field of cancer nanomedicine was the right decision. It is very rewarding to see how after more than 10 years of work on C dots this is now all coming to fruition," Wiesner said.
-end-
Cornell University has television, ISDN and dedicated Skype/Google+ Hangout studios available for media interviews.

Cornell University

Related Cancer Articles:

Cancer mortality continues steady decline, driven by progress against lung cancer
The cancer death rate declined by 29% from 1991 to 2017, including a 2.2% drop from 2016 to 2017, the largest single-year drop in cancer mortality ever reported.
Stress in cervical cancer patients associated with higher risk of cancer-specific mortality
Psychological stress was associated with a higher risk of cancer-specific mortality in women diagnosed with cervical cancer.
Cancer-sniffing dogs 97% accurate in identifying lung cancer, according to study in JAOA
The next step will be to further fractionate the samples based on chemical and physical properties, presenting them back to the dogs until the specific biomarkers for each cancer are identified.
Moffitt Cancer Center researchers identify one way T cell function may fail in cancer
Moffitt Cancer Center researchers have discovered a mechanism by which one type of immune cell, CD8+ T cells, can become dysfunctional, impeding its ability to seek and kill cancer cells.
More cancer survivors, fewer cancer specialists point to challenge in meeting care needs
An aging population, a growing number of cancer survivors, and a projected shortage of cancer care providers will result in a challenge in delivering the care for cancer survivors in the United States if systemic changes are not made.
New cancer vaccine platform a potential tool for efficacious targeted cancer therapy
Researchers at the University of Helsinki have discovered a solution in the form of a cancer vaccine platform for improving the efficacy of oncolytic viruses used in cancer treatment.
American Cancer Society outlines blueprint for cancer control in the 21st century
The American Cancer Society is outlining its vision for cancer control in the decades ahead in a series of articles that forms the basis of a national cancer control plan.
Oncotarget: Cancer pioneer employs physics to approach cancer in last research article
In the cover article of Tuesday's issue of Oncotarget, James Frost, MD, PhD, Kenneth Pienta, MD, and the late Donald Coffey, Ph.D., use a theory of physical and biophysical symmetry to derive a new conceptualization of cancer.
Health indicators for newborns of breast cancer survivors may vary by cancer type
In a study published in the International Journal of Cancer, researchers from the UNC Lineberger Comprehensive Cancer Center analyzed health indicators for children born to young breast cancer survivors in North Carolina.
Few women with history of breast cancer and ovarian cancer take a recommended genetic test
More than 80 percent of women living with a history of breast or ovarian cancer at high-risk of having a gene mutation have never taken the test that can detect it.
More Cancer News and Cancer Current Events

Trending Science News

Current Coronavirus (COVID-19) News

Top Science Podcasts

We have hand picked the top science podcasts of 2020.
Now Playing: TED Radio Hour

Listen Again: Reinvention
Change is hard, but it's also an opportunity to discover and reimagine what you thought you knew. From our economy, to music, to even ourselves–this hour TED speakers explore the power of reinvention. Guests include OK Go lead singer Damian Kulash Jr., former college gymnastics coach Valorie Kondos Field, Stockton Mayor Michael Tubbs, and entrepreneur Nick Hanauer.
Now Playing: Science for the People

#562 Superbug to Bedside
By now we're all good and scared about antibiotic resistance, one of the many things coming to get us all. But there's good news, sort of. News antibiotics are coming out! How do they get tested? What does that kind of a trial look like and how does it happen? Host Bethany Brookeshire talks with Matt McCarthy, author of "Superbugs: The Race to Stop an Epidemic", about the ins and outs of testing a new antibiotic in the hospital.
Now Playing: Radiolab

Dispatch 6: Strange Times
Covid has disrupted the most basic routines of our days and nights. But in the middle of a conversation about how to fight the virus, we find a place impervious to the stalled plans and frenetic demands of the outside world. It's a very different kind of front line, where urgent work means moving slow, and time is marked out in tiny pre-planned steps. Then, on a walk through the woods, we consider how the tempo of our lives affects our minds and discover how the beats of biology shape our bodies. This episode was produced with help from Molly Webster and Tracie Hunte. Support Radiolab today at Radiolab.org/donate.